Disease Burden and Associated Risk Factors of Early-Onset Lung Cancer in China and Worldwide

ObjectiveTo assess the global and Chinese disease burden of early-onset lung cancer(diagnosed in patients aged 15-49 years) and its major risk factors.MethodsBased on the GLOBOCAN 2022 and Global Burden of Disease(GBD) 2021 datasets, we evaluated the disease burden and associated risk factors of ear...

Full description

Saved in:
Bibliographic Details
Main Authors: CAI Lin, ZHU Chenxin, YUAN Jiani, ZHANG Xinglong, FANG Yi, YANG Haiyan, GUO Lanwei
Format: Article
Language:zho
Published: Editorial Office of Medical Journal of Peking Union Medical College Hospital 2025-07-01
Series:Xiehe Yixue Zazhi
Subjects:
Online Access:https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-1097
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849392755539705856
author CAI Lin
ZHU Chenxin
YUAN Jiani
ZHANG Xinglong
FANG Yi
YANG Haiyan
GUO Lanwei
author_facet CAI Lin
ZHU Chenxin
YUAN Jiani
ZHANG Xinglong
FANG Yi
YANG Haiyan
GUO Lanwei
author_sort CAI Lin
collection DOAJ
description ObjectiveTo assess the global and Chinese disease burden of early-onset lung cancer(diagnosed in patients aged 15-49 years) and its major risk factors.MethodsBased on the GLOBOCAN 2022 and Global Burden of Disease(GBD) 2021 datasets, we evaluated the disease burden and associated risk factors of early-onset lung cancer globally and in China, stratified by age, sex, geographic location, and human development index(HDI). Key indicators included age-standardized incidence rate(ASIR), age-standardized mortality rate(ASMR), and disability adjusted life years(DALYs) attributable to risk factors.ResultsIn 2022, there were 137 705 new cases and 72 646 deaths from early-onset lung cancer globally, with ASIR and ASMR of 3.43 per 100 000 and 1.82 per 100 000 population, respectively. The disease burden was higher in males than in females(ASIR: 3.72 per 100 000 vs. 3.14 per 100 000; ASMR: 2.31 per 100 000 vs. 1.33 per 100 000). High-HDI regions exhibited the highest ASIR(5.51 per 100 000) and ASMR(2.57 per 100 000), with health inequality analysis revealing a concentration of disease burden in higher-HDI areas. China bore the heaviest burden, accounting for 48.69% of global new cases and 35.77% of deaths. China's ASIR(8.21 per 100 000) and ASMR(3.17 per 100 000) exceeded global averages, with incidence higher in females(8.78 per 100 000 vs. 7.67 per 100 000) but mortality higher in males(4.01 per 100 000 vs. 2.29 per 100 000). Smoking and ambient particulate matter pollution were the leading risk factors globally(DALYs contribution: 42.01% and 15.62%) and in China(DALYs contribution: 46.78% and 20.84%). Globally, household air pollution ranked third, whereas in China, secondhand smoke replaced it as the third leading risk factor, with household air pollution dropping to fifth. Risk factor profiles varied significantly across age groups, with modifiable risks contributing less to disease burden in the 15-24 age group.ConclusionsThe burden of early-onset lung cancer varies markedly by sex, region, and HDI, with China facing a disproportionately high burden. Policymakers should prioritize equitable resource allocation and targeted interventions, particularly in tobacco control and air pollution mitigation, to enhance cancer prevention and control efforts.
format Article
id doaj-art-1e13b17f14924e56b1d3aa1ea9d9667d
institution Kabale University
issn 1674-9081
language zho
publishDate 2025-07-01
publisher Editorial Office of Medical Journal of Peking Union Medical College Hospital
record_format Article
series Xiehe Yixue Zazhi
spelling doaj-art-1e13b17f14924e56b1d3aa1ea9d9667d2025-08-20T03:40:42ZzhoEditorial Office of Medical Journal of Peking Union Medical College HospitalXiehe Yixue Zazhi1674-90812025-07-011641047105610.12290/xhyxzz.2024-1097Disease Burden and Associated Risk Factors of Early-Onset Lung Cancer in China and WorldwideCAI LinZHU ChenxinYUAN JianiZHANG XinglongFANG YiYANG Haiyan0GUO LanweiDepartment of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou 450001, ChinaObjectiveTo assess the global and Chinese disease burden of early-onset lung cancer(diagnosed in patients aged 15-49 years) and its major risk factors.MethodsBased on the GLOBOCAN 2022 and Global Burden of Disease(GBD) 2021 datasets, we evaluated the disease burden and associated risk factors of early-onset lung cancer globally and in China, stratified by age, sex, geographic location, and human development index(HDI). Key indicators included age-standardized incidence rate(ASIR), age-standardized mortality rate(ASMR), and disability adjusted life years(DALYs) attributable to risk factors.ResultsIn 2022, there were 137 705 new cases and 72 646 deaths from early-onset lung cancer globally, with ASIR and ASMR of 3.43 per 100 000 and 1.82 per 100 000 population, respectively. The disease burden was higher in males than in females(ASIR: 3.72 per 100 000 vs. 3.14 per 100 000; ASMR: 2.31 per 100 000 vs. 1.33 per 100 000). High-HDI regions exhibited the highest ASIR(5.51 per 100 000) and ASMR(2.57 per 100 000), with health inequality analysis revealing a concentration of disease burden in higher-HDI areas. China bore the heaviest burden, accounting for 48.69% of global new cases and 35.77% of deaths. China's ASIR(8.21 per 100 000) and ASMR(3.17 per 100 000) exceeded global averages, with incidence higher in females(8.78 per 100 000 vs. 7.67 per 100 000) but mortality higher in males(4.01 per 100 000 vs. 2.29 per 100 000). Smoking and ambient particulate matter pollution were the leading risk factors globally(DALYs contribution: 42.01% and 15.62%) and in China(DALYs contribution: 46.78% and 20.84%). Globally, household air pollution ranked third, whereas in China, secondhand smoke replaced it as the third leading risk factor, with household air pollution dropping to fifth. Risk factor profiles varied significantly across age groups, with modifiable risks contributing less to disease burden in the 15-24 age group.ConclusionsThe burden of early-onset lung cancer varies markedly by sex, region, and HDI, with China facing a disproportionately high burden. Policymakers should prioritize equitable resource allocation and targeted interventions, particularly in tobacco control and air pollution mitigation, to enhance cancer prevention and control efforts.https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-1097early-onset lung cancerincidencemortalityrisk factorsdisease burden
spellingShingle CAI Lin
ZHU Chenxin
YUAN Jiani
ZHANG Xinglong
FANG Yi
YANG Haiyan
GUO Lanwei
Disease Burden and Associated Risk Factors of Early-Onset Lung Cancer in China and Worldwide
Xiehe Yixue Zazhi
early-onset lung cancer
incidence
mortality
risk factors
disease burden
title Disease Burden and Associated Risk Factors of Early-Onset Lung Cancer in China and Worldwide
title_full Disease Burden and Associated Risk Factors of Early-Onset Lung Cancer in China and Worldwide
title_fullStr Disease Burden and Associated Risk Factors of Early-Onset Lung Cancer in China and Worldwide
title_full_unstemmed Disease Burden and Associated Risk Factors of Early-Onset Lung Cancer in China and Worldwide
title_short Disease Burden and Associated Risk Factors of Early-Onset Lung Cancer in China and Worldwide
title_sort disease burden and associated risk factors of early onset lung cancer in china and worldwide
topic early-onset lung cancer
incidence
mortality
risk factors
disease burden
url https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-1097
work_keys_str_mv AT cailin diseaseburdenandassociatedriskfactorsofearlyonsetlungcancerinchinaandworldwide
AT zhuchenxin diseaseburdenandassociatedriskfactorsofearlyonsetlungcancerinchinaandworldwide
AT yuanjiani diseaseburdenandassociatedriskfactorsofearlyonsetlungcancerinchinaandworldwide
AT zhangxinglong diseaseburdenandassociatedriskfactorsofearlyonsetlungcancerinchinaandworldwide
AT fangyi diseaseburdenandassociatedriskfactorsofearlyonsetlungcancerinchinaandworldwide
AT yanghaiyan diseaseburdenandassociatedriskfactorsofearlyonsetlungcancerinchinaandworldwide
AT guolanwei diseaseburdenandassociatedriskfactorsofearlyonsetlungcancerinchinaandworldwide